Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Introduction: standards of antibacterial performance.

R G Finch1

  • 1Department of Microbiology and Infectious Disease, City Hospital and University of Nottingham, Nottingham NG5 1PB, UK. r.finch@nottingham.ac.uk

Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
|February 5, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

GRACE and the development of an education and training curriculum.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2012
Same author

Sporicides for Clostridium difficile: the devil is in the detail.

The Journal of hospital infection·2011
Same author

Safety and efficacy of glycopeptide antibiotics.

The Journal of antimicrobial chemotherapy·2005
Same author

Hepatitis C virus infection.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2005
Same author

Immunomodulating activity of rifampicin.

Journal of chemotherapy (Florence, Italy)·2004
Same author

Sales of over-the-counter remedies as an early warning system for winter bed crises.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2003
Same journal

Impact of low-dose chest CT and multiplex PCR on antibiotic usage for community-acquired pneumonia: multicentre prospective controlled before-after study with cluster randomisation (CAP-NEXT study).

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2026
Same journal

Clinical Microbiology and Infection: how did we do in 2025?

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2026
Same journal

Automate the work, not the decision: aligning expectations for AI in clinical microbiology.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2026
Same journal

Doxycycline prophylaxis and gonococcal resistance: reassurance, residual signals, and the case for surveillance.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2026
Same journal

Oral metronidazole versus clindamycin to treat bacterial vaginosis in pregnancies at risk for preterm labor.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2026
Same journal

Efficacy and safety of a radiographic severity-stratified all-oral short treatment regimen for multidrug/rifampicin-resistant tuberculosis in China: An open-label, multi-center,randomized controlled, non-inferiority trial.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2026
See all related articles

Antimicrobial drug development is evolving, with pharmacokinetics and pharmacodynamics guiding new therapies. Optimizing existing antimicrobial agents and developing new formulations are crucial for combating resistance and improving patient outcomes.

Area of Science:

  • Microbiology
  • Pharmacology
  • Infectious Diseases

Background:

  • Antimicrobial agent development and clinical use are constantly advancing.
  • Antimicrobial resistance (AMR) is a significant factor in drug development and treatment selection.
  • Pharmacokinetic (PK) and pharmacodynamic (PD) parameters are increasingly vital for defining performance targets of antimicrobial agents.

Purpose of the Study:

  • To review antimicrobial prescribing in light of new scientific knowledge, particularly PK/PD.
  • To address the evolving landscape of antimicrobial resistance, especially in respiratory pathogens.
  • To explore strategies for maintaining optimal therapeutic outcomes and limiting the spread of resistant strains.

Main Methods:

  • Literature review and analysis of current trends in antimicrobial drug development and clinical application.

Related Experiment Videos

  • Examination of the role of PK/PD in setting performance targets for antimicrobial agents.
  • Assessment of strategies to combat antimicrobial resistance, including new agent development and formulation optimization.

    • Main Results:

    • New antimicrobial therapies are primarily for hospital-associated Gram-positive infections.
    • Community treatment relies on established antimicrobial agents from limited classes.
    • Antimicrobial resistance is evolving, necessitating updated therapeutic strategies.

    Conclusions:

    • Optimizing dosage regimens and antimicrobial choices based on PK/PD is essential.
    • Developing new formulations of existing agents can overcome current resistance patterns.
    • A multi-faceted approach, including new agent development and improved prescribing practices, is needed to manage antimicrobial resistance effectively.